Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01814137
What this trial is testing

A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 40
Early research (Phase 1)Study completedNCT03436498
What this trial is testing

Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 45
Early research (Phase 1)Study completedNCT04237129
What this trial is testing

PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males

Who this might be right for
Diabetes Mellitus, Type 1
Gan and Lee Pharmaceuticals, USA 36
Post-approval studies (Phase 4)Study completedNCT00184561
What this trial is testing

Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 321
Not applicableStudy completedNCT04184466
What this trial is testing

Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

Who this might be right for
Clamp Study
Geropharm 26
Testing effectiveness (Phase 2)Study completedNCT03981627
What this trial is testing

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Adocia 44
Large-scale testing (Phase 3)Study completedNCT03977727
What this trial is testing

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Who this might be right for
Type 1 Diabetes Mellitus
Texas Diabetes & Endocrinology, P.A. 40
Post-approval studies (Phase 4)Study completedNCT00605111
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 193
Early research (Phase 1)Study completedNCT01773798
What this trial is testing

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 33
Post-approval studies (Phase 4)Study completedNCT00572806
What this trial is testing

Initiation of Insulin Aspart in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 6
Testing effectiveness (Phase 2)Study completedNCT01194245
What this trial is testing

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
Halozyme Therapeutics 135
Post-approval studies (Phase 4)Study completedNCT00571935
What this trial is testing

Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 61
Not applicableStudy completedNCT00659282
What this trial is testing

Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 57,610
Testing effectiveness (Phase 2)Study completedNCT00539396
What this trial is testing

A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 1
Mannkind Corporation 110
Post-approval studies (Phase 4)WithdrawnNCT00663624
What this trial is testing

Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care

Who this might be right for
Diabetes
Emory University
Large-scale testing (Phase 3)Study completedNCT00627445
What this trial is testing

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 441
Post-approval studies (Phase 4)Study completedNCT00101751
What this trial is testing

INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 4,877
Post-approval studies (Phase 4)Study completedNCT00184626
What this trial is testing

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 97
Testing effectiveness (Phase 2)Study completedNCT00612040
What this trial is testing

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 178
Early research (Phase 1)Study completedNCT05754424
What this trial is testing

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 2
Arecor Limited 41
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation